Market Rank #50 · Evidence Tier A

Saudi Arabia
Neuroscience Intelligence

Saudi Arabia neuroscience intelligence: 12 indexed trials, 12 institutions, research score 19.83.

⚗
12Indexed trials
↗
3Recruiting
⌂
12Research institutions
◎
19.8Research score

Evidence profile

11Sponsors
7Disease areas
0Institution works
0Institution citations

Model signals

Opportunity 20 · ML priority 20 · Confidence 100 · Evidence 19.8

These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.

Leading disease areas

adhd2trials
cerebral_palsy2trials
epilepsy2trials
other_neurology2trials
pain_neuropathy2trials
multiple_sclerosis1trials

Leading indexed sponsors

King Saud University2trials
Hoffmann-La Roche1trials
Imam Abdulrahman Bin Faisal University1trials
King Abdullah International Medical Research Center1trials
King Khalid University1trials
Middle East North Africa Stroke and Interventional Neurotherapies Organization1trials
Novartis Pharmaceuticals1trials
Sajjad Rahman1trials
University of Hail1trials
Alexandria University1trials